Concepedia
Statistics
Publications
19
Citations
456
H-Index
14
Active since
1992
Affiliations
AbbVie (United States)(Current)
Abbott (United States)
Abbott Fund
Rensselaer Polytechnic Institute
Abbott (United Kingdom)
Kevin P. Cusack is an author at AbbVie (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.
Publications per year
1992–2023
Emerging technologies for metabolite generation and structural diversification
Kevin P. Cusack, Hannes F. Koolman, Udo E. W. Lange et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 66 citations · Full text
Pharmacy, Chemical Engineering, Medicinal Chemistry +13
Sulfonylation of organometallic reagents with arenesulfonyl fluorides: a simple one-step synthesis of sulfones
Leah L. Frye, Eileen L. Sullivan, Kevin P. Cusack et al. · The Journal of Organic Chemistry · 1992 · 64 citations
Natural Sciences, Chemistry, Green Chemistry +5
Cu(I)-catalyzed intramolecular cyclization of ene-carbamates: synthesis of indoles and pyrrolo[2,3-c]pyridines
Claude Barberis, Thomas D. Gordon, C. B. Thomas et al. · Tetrahedron Letters · 2005 · 38 citations
Natural Sciences, Chemistry, Medicinal Chemistry +8
Identification of a selective thieno[2,3-c]pyridine inhibitor of COT kinase and TNF-α production
Kevin P. Cusack, Hamish Allen, Agnieszka K. Bischoff et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 28 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +7
32-Methyl-32-oxylanosterols: dual-action inhibitors of cholesterol biosynthesis
Leah L. Frye, Kevin P. Cusack, Deborah A. Leonard · Journal of Medicinal Chemistry · 1993 · 28 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +13
1–5 of 19